OneMedNet Corporation (ONMD)

NASDAQ: ONMD · USD

$4.40

+0.00 (0.0%)· Recorded snapshot

Market cap	26.5M
Revenue (ttm)	1.5M
Net income (ttm)	-8.4M
EPS (ttm)	-$1.53
Shares out	6M
Volume	6,785
Beta	1.15

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.5M
Net income (ttm): -8.4M
EPS (ttm): -$1.53
Market cap: 26.5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ONMD indicators

Market & fundamental data

Available fields

188

Groups with data

Currency

USD

Showing 188 of 188 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001849380
Company name	OneMedNet Corporation
Country	United States
Country code	US
CUSIP number	68270C202
Earnings date	2026-11-13
Earnings time	amc
Employees	23
Employees change	3
Employees growth	15%
Enterprise value	$26.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2006
Industry	Health Information Services
Is primary listing	Yes
Is SPAC	No
ISIN number	US68270C2026
Last 10-K release date	2026-03-30
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-09-29
Last stock split type	Reverse
Market cap	$26.5M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$4.40
Price currency	USD
Sector	Healthcare
SIC code	8731
Stock price date	2026-10-28
Symbol	ONMD
U.S. state	Minnesota
Website	https://www.onemednet.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-34.69%
EV/Sales	19.08x
FCF / EV yield	-24.83%
FCF yield	-25.14%
Industry forward P/E	35.4x
P/S ratio	18.84x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-83.3%
Operating margin	-696.15%
Pretax margin	-584.54%
Profit per employee	$-366,348
Revenue per employee	$63,261
ROA	-342.1%
ROA (5Y)	-169.03%
ROCE	301.28%
SBC / revenue	173.26%
Tax / revenue	0.07%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Net income growth years	2
Revenue growth	216.99%
Revenue growth (Q)	88.39%
Revenue growth (QoQ)	204.17%
Revenue growth 3Y	13.51%
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-16,000
Depreciation and amortization	$35,000
EBIT	$-10.1M
EBITDA	$-10.1M
EPS	$-1.53
FCF per share	$-1.15
Financing cash flow	$5.6M
Free cash flow	$-6.9M
Free cash flow minus SBC	$-9.4M
Gross profit	$-1.2M
Income taxes	$1,000
Investing cash flow	$1.5M
Net borrowing	$-485,000
Net cash flow	$236,000
Net income	$-8.4M
Operating cash flow minus SBC	$-9.4M
Operating income	$-10.1M
Revenue	$1.5M
Stock-based compensation	$2.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-132.06
Book value per share	$-0.61
Interest coverage	-297.91
Long-term assets	$51,000
Long-term liabilities	$156,000
Net cash (debt)	$-343,000
Net cash / market cap	-1.25%
Piotroski F-Score	3
Property, plant and equipment	$51,000
Shareholders' equity	$-3.5M
Tangible book value	$-3.5M
Tangible book value per share	$-0.61
Total assets	$1.4M
Total cash	$358,000
Total debt	$701,000
Total liabilities	$4.9M
WACC	10.39%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.79
Current assets	$1.3M
Current liabilities	$4.7M
Current ratio	0.28
Net working capital	$-3.2M
Quick ratio	0.22
Working capital	$-3.4M
Working capital turnover	-0.4

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-65.6%
Dividend yield	0%
Shareholder yield	-65.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$7.09
1D price change	0%
1M price change	-32.36%
1M total return	-32.36%
1W price change	-7.41%
1W total return	-7.41%
1Y price change	-80.72%
1Y return CAGR	-80.74%
1Y total return	-80.72%
20-day SMA	$4.69
200-day SMA	$7.27
3M price change	-27.44%
3M total return	-27.44%
3Y price change	-93.23%
3Y return CAGR	-59.23%
3Y total return	-93.23%
50-day SMA	$5.62
50-day SMA vs 200-day SMA	50under200
52-week high	$24.00
52-week high date	2025-10-29
52-week low	$3.61
52-week low date	2026-10-13
5Y price change	-95.63%
5Y return CAGR	-46.53%
5Y total return	-95.63%
6M price change	-63.36%
6M total return	-63.36%
All-time high	$135.10
All-time high date	2023-10-25
All-time low	$3.00
All-time low date	2025-04-22
Average true range (ATR)	$0.42
Average volume	31.4K
Beta (1Y)	1.55
Beta (2Y)	-0.38
Beta (5Y)	1.15
Change from 52-week high	-81.67%
Change from 52-week low	21.88%
Change from all-time high	-96.75%
Change from all-time low	46.54%
Change from open	0%
Day's gap	0%
Dollar volume	$29,854
High price	$4.40
Low price	$4.30
Monthly RSI	36.39
Open price	$4.40
Position in 52-week range	100%
Premarket change	-0.66%
Premarket close	$4.40
Premarket price	$4.37
Previous close	$4.40
Price vs 150-day SMA	-37.99%
Price vs 20-day SMA	-6.22%
Price vs 200-day SMA	-39.52%
Price vs 50-day SMA	-21.7%
Relative volume	0.22
RSI	39.71
Sharpe ratio	-0.66
Sharpe ratio (3Y)	0.43
Sortino ratio	-0.95
Sortino ratio (3Y)	1.13
Volume	6.8K
Weekly RSI	40.17
YTD price change	-60.03%
YTD total return	-60.03%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2M
Float percentage	33.42%
Shares change (QoQ)	4.89%
Shares change (YoY)	65.6%
Shares held by insiders	59.95%
Shares held by institutions	35.58%
Shares outstanding	6M
Short % of float	5.65%
Short % of shares	1.89%
Short ratio	1.9 days

Deeper analysis on ONMD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ONMD report

Is a complete ONMD research report available?

No complete published report is available for OneMedNet Corporation (ONMD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

OneMedNet Corporation (ONMD)

Price

Financial snapshot

Fair-value bridge

Latest news · ONMD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ONMD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ONMD

Frequently asked questions